This constant engagement helps in compliance to treatment and safety particularly during the early stages of treatment
Weight loss is 12.4% in trials (vs 15-22% for injectables), but self-pay pricing is significantly lower ($149-$349/month vs $1,000+/month for injectables)
[,] The insulin-tropic activity of GIP is shortened in T2DM patients, but it is restored near normalization after administration of insulin for up to 4 weeks
With this unforeseen side-effect, researchers at the University of Leeds and Novo Nordisk (the company that produces Semaglutide) conjectured that it can also be used for the treatment of obesity
Symptoms of low blood sugar include shaking, sweating, headaches, tachycardia, fatigue, anxiety, confusion, irritability, nausea, and intense hunger
What it does do is reduce appetite and carbohydrate cravings, which makes adhering to a ketogenic diet considerably easier than it would be otherwise